Ginkgo Bioworks Holdings (DNA) Change in Inventory (2020 - 2023)
Ginkgo Bioworks Holdings' (DNA) quarterly Change in Inventory came in at -$694000.0 in Q2 2023, down 16.64% YoY from -$832520.2 in Q2 2022, and up 62.59% on a QoQ basis from -$1.9 million in Q1 2023.
Ginkgo Bioworks Holdings (DNA) Change in Inventory (2020 - 2023) Analysis & Trends
Ginkgo Bioworks Holdings (DNA) has 4 years of Change in Inventory data on file, last reported at -$694000.0 in Q2 2023.
- Quarterly Change in Inventory fell 16.64% year-over-year to -$694000.0 in Q2 2023, while the trailing twelve-month figure through Jun 2023 was -$7.5 million (down 238.38% YoY) and the FY2022 annual result came in at -$164000.0, down 126.2% from the prior year.
- Change in Inventory rose to -$694000.0 in Q2 2023, from -$1.9 million in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $5.3 million in Q1 2022 to a low of -$2.7 million in Q4 2022.
- A 4-year average of -$15454.5 and a median of -$595000.0 in 2022 frame the typical range for Change in Inventory.
- The widest YoY moves for Change in Inventory: up 683.41% in 2022, down 2276.79% in 2022.
- Tracing DNA's Change in Inventory over 4 years: stood at $1.9 million in 2020, then tumbled by 105.84% to -$112000.0 in 2021, then slumped by 2276.79% to -$2.7 million in 2022, then jumped by 73.93% to -$694000.0 in 2023.
- The last three Change in Inventory figures came in at -$694000.0 (Q2 2023), -$1.9 million (Q1 2023), and -$2.7 million (Q4 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 47.15 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2,188.52 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -280,000.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 12.97 Mn |
| 10 | Ginkgo Bioworks Holdings | 432.60 Mn | 348.06 Mn | 18.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -694,000.00 |
| Jun 30, 2023 | -694,000.00 |
| Mar 31, 2023 | -1.86 Mn |
| Mar 31, 2023 | -1.86 Mn |
| Dec 31, 2022 | -2.66 Mn |
| Dec 31, 2022 | -2.66 Mn |
| Sep 30, 2022 | -2.24 Mn |
| Sep 30, 2022 | -2.24 Mn |
| Jun 30, 2022 | -595,000.00 |
| Jun 30, 2022 | -595,000.00 |
| Mar 31, 2022 | 5.34 Mn |
| Mar 31, 2022 | 5.34 Mn |
| Dec 31, 2021 | -112,000.00 |
| Dec 31, 2021 | -112,000.00 |
| Sep 30, 2021 | 758,000.00 |
| Sep 30, 2021 | 758,000.00 |
| Jun 30, 2021 | -701,000.00 |
| Jun 30, 2021 | -701,000.00 |
| Mar 31, 2021 | 681,000.00 |
| Mar 31, 2021 | 681,000.00 |